Glint Pharmaceuticals Begins Clinical Trials to Treat Corneal Abrasions and Infections
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the start of a phase I safety study to treat corneal infections and superficial injuries.
UF Health Researchers Join Global Effort To Track COVID-19 Pandemic and Others in Future
University of Florida Health researchers are joining an ambitious global effort led by The Rockefeller Foundation to better track the coronavirus and its variants and set up a network of collaborators to stop any nascent pandemic in the future.
Atsena Therapeutics Appoints Kenji Fujita, MD, as Chief Medical Officer
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced the appointment of Kenji Fujita, MD, to the newly created position of Chief Medical Officer.
Karl LaPan, New UF Innovate Director, Plans Continued Growth, Success for Program
Following a record-breaking year of growth for Alachua’s biotechnology industry, the University of Florida’s programs for entrepreneurial incubation and innovation, UF Innovate, has hired a new director of incubation services who’s looking to continue the program’s upward trajectory.
UF Creates Antibacterial Agents to Help Eradicate Antibiotic-Resistant Bacteria
UF medicinal chemists report promising results from a study focused on new ways to of treating several types of antibiotic-resistant bacteria, advances that may help in the battle against MRSA, tuberculosis and other infectious pathogens.
Phase 3 ePHex Study: OxThera Reports Results
Sid Martin Biotech alum OxThera AB, a biopharma company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces results of its pivotal Phase 3 study.
Inspira Awarded $1.98M NIH Grant for Diabetes Therapy
Inspira Therapeutics was awarded a $1.98 million NIH grant to develop its polymeric biomaterial-based tolerogenic treatment for type 1 diabetes.
Gator Alumna Launches Byppocampus, an Eco-Friendly, Student-to-Student Campus Food Delivery Program
UF Innovate | The Hub resident Byppo Technologies, Gainesville’s innovative local food service platform, is partnering with Aramark, a global leader of acclaimed services in food, facilities, and uniforms, to bring a revolutionary campus dining experience to the University of Florida.
Setlow and Bizon Co-Edit Behavioural Brain Research Journal
Barry Setlow, Ph. D. and Jen Bizon, Ph.D. co-edit an invitational special issue of the Behavioural Brain Research journal titled “Amygdala and value-based decision making,” based on related previous work.
Morphogenesis Awarded SBIR Funding for Cervical Cancer Therapy
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, has obtained funding to develop a new therapeutic drug to treat cervical cancer.
